Merck & Co. Inc. buy Barclays PLC
Start price
20.02.26
/
50%
€103.80
Target price
20.02.27
€119.08
Performance (%)
-0.25%
Price
10.04.26
€103.54
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Merck & Co. Inc. is nearly unchanged. This prediction currently runs until 20.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | -1.390% | -1.390% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $140.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.90
07.10.24
07.10.24
€127.58
07.10.25
07.10.25
-23.46%
08.10.25
08.10.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.14
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€116.60
02.02.24
02.02.24
€134.11
02.02.25
02.02.25
-18.18%
03.02.25
03.02.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€108.20
23.01.24
23.01.24
€124.16
23.01.25
23.01.25
-14.23%
24.01.25
24.01.25